J P Morgan Chase & Co Reiterates Neutral Rating for Cambian Group PLC (CMBN)
Cambian Group PLC (LON:CMBN)‘s stock had its “neutral” rating restated by equities researchers at J P Morgan Chase & Co in a research report issued to clients and investors on Thursday. They presently have a GBX 139 ($1.87) target price on the health services provider’s stock. J P Morgan Chase & Co’s price target would indicate a potential downside of 31.02% from the company’s previous close.
A number of other research analysts have also recently weighed in on the company. Liberum Capital assumed coverage on Cambian Group PLC in a research report on Tuesday, August 1st. They set a “buy” rating and a GBX 224 ($3.02) price objective on the stock. Numis Securities Ltd cut Cambian Group PLC to a “hold” rating and set a GBX 200 ($2.70) price objective on the stock. in a research report on Wednesday.
Shares of Cambian Group PLC (CMBN) opened at 201.50 on Thursday. The stock’s market capitalization is GBX 364.67 million. The firm’s 50-day moving average is GBX 220.07 and its 200 day moving average is GBX 177.05. Cambian Group PLC has a 12-month low of GBX 92.00 and a 12-month high of GBX 237.00.
Cambian Group PLC Company Profile
Cambian Group plc is a provider of specialist behavioral health services for children in the United Kingdom. The Company’s children services include specialist education services, specialist residential care services, foster care services and specialist mental health services. Its schools provide support to children with Autism, Asperger’s Syndrome, severe learning disabilities, challenging behavior and complex needs.
Receive News & Stock Ratings for Cambian Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambian Group PLC and related stocks with our FREE daily email newsletter.